Dallas, TX: ReportsandReports announce Cephalon Inc.: PharmaVitae Profile Market Research Report in its Store.
Browse complete Report at: http://www.reportsandreports.com/reports/9245-cephalon-inc-pharmavitae-profile.html
This analysis examines the historical and forecast performance for Cephalon in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
• Benchmark Cephalon’s performance against key rivals in the prescription pharmaceutical sector
• Discover the impact of genericization of Provigil and assess the effectiveness of the company’s lifecycle management strategy to cope with this
• Assess the increasing importance of emerging therapy areas in order to sustain growth
• Table Of Contents
• ABOUT DATAMONITOR HEALTHCARE 2
About the PharmaVitae team 2
• Chapter 1 About this profile 3
• PharmaVitae Explorer database 3
Chapter structure 3
Executive summary 3
Quarterly news update 3
Company introduction 3
Company sales 4
Company financials 4
Key products and competitors 4
Data sourcing 4
Sales data 4
Analyst consensus 4
• Chapter 2 Executive summary 5
• Key findings 5
Prescription pharmaceutical sales and growth rate performance, 2002-14 6
Financial performance, 2002-14 7
Cephalon: PharmaVitae forecasts at a glance 8
Strategic insight 9
Strong growth from Provigil and Actiq makes Cephalon a CNS-centric player 9
Generic sales erosion of key products only slightly offset by product lifecycle management strategies 9
Cephalon’s lifecycle management strategy: generics have the final word 9
The CNS therapy area is one undergoing significant generic sales erosion 12
Cephalon acquires in order to diversify 13
SWOT analysis 16
• Table of Contents 17
• Table of figures 19
• Chapter 3 Quarterly news update 20
• Product developments 20
Deals and alliances 22
Product deals 22
Technology deals 23
M&A activity 24
Company announcements 25
Future product milestones 26
• Chapter 4 Company introduction 27
• Key findings 27
Background 28
Key corporate developments 28
M&A history 28
CIMA Labs: a story of lifecycle management 28
Salmedix: branching out into oncology 28
Zeneus Holdings: gaining a foothold into Europe 28
Product acquisitions: Amrix, developing a new therapeutic interest 29
Acquisitive year in 2009 29
• Chapter 5 Company sales 31
• Key findings 31
Prescription pharmaceutical sales and growth rate analysis, 2002-14 32
Product analysis 33
Product analysis, 2002-08 35
Product analysis, 2008-14 37
Therapy area analysis 40
Geographic analysis 42
Launch/core/expiry analysis 44
Explanation of launch/core/expiry analysis 44
Launch analysis, 2008-14 45
Core analysis, 2008-14 46
Expiry analysis, 2008-14 47
Launch/core/expiry configuration, 2008-14 48
Molecule type analysis 49
Externalization analysis 51
• Chapter 6 Company financials 53
• Key findings 53
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08 54
Operating costs and profit analysis 55
Operating costs and profit analysis, 2002-08 56
Operating cost ratio and profit margin analysis, 2002-08 57
Operating cost ratio and profit margin analysis, 2008-14 58
Operating costs and profit analysis, 2008-14 59
• Chapter 7 Key products and competitors 60
• Key findings 60
Overview 61
Central nervous system 62
Provigil 62
Overview 62
Sales forecast 63
Nuvigil 65
Overview 65
Sales forecast 66
Actiq 68
Overview 68
Sales forecast 69
Fentora 71
Overview 71
Sales forecast 72
Subsection 1 72
Oncology 74
Treanda 74
Overview 74
Sales forecast 75
• Chapter 8 Appendix 77
• Abbreviations 77
About Datamonitor 78
About Datamonitor Healthcare 78
Datamonitor consulting 78
Disclaimer 80
ABBREVIATIONS
Browse all : Healthcare Market Research Reports
http://www.reportsandreports.com/cat/healthcare-market-research.html
Browse all : Datamonitor Market Research Reports
http://www.reportsandreports.com/Publisher/datamonitor-market-research.html-market-research.html
Browse all Newly Published Market Research Reports
http://www.reportsandreports.com/LatestReport.aspx
Original Source : PharmaV itae Market
http://www.reportsandreports.com/reports/9245-cephalon-inc-pharmavitae-profile.html
Buy Now : Market Research Report
http://www.reportsandreports.com/
Related Reports:
Browse all : Cephalon Inc-Deals & Alliances Report
http://www.reportsandreports.com/reports/31264-cephalon-inc-deals-alliances-report.html
Browse all :Cephalon Inc-Detailed Product Pipeline
http://www.reportsandreports.com/reports/3763-cephalon-inc-detailed-product-pipeline.html
Browse all : Cephalon Inc.-Deals & Alliances Report
http://www.reportsandreports.com/reports/4205-cephalon-inc-deals-alliances-report.html
Browse all : Cephalon Inc-Therapeutic Competitors
http://www.reportsandreports.com/reports/3329-cephalon-inc-therapeutic-competitors.html
Browse all : Cephalon, Inc. – SWOT Analysis
http://www.reportsandreports.com/reports/2020-cephalon-inc-swot-analysis.html
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
